Elena Vendrame

9PUBLICATIONS
61CO-AUTHORS
Epidemiological methodsInnate immunityGene and molecular therapyVirologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 08, 2025
Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._.

Lucia Bailón, Yovaninna Alarcón-Soto, José R Arribas

|Dec 01, 2025
Correlates of HIV-1 control after combination immunotherapy.

M J Peluso, D A Sandel, A N Deitchman

|Mar 04, 2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.

Lucia Bailón, José Moltó, Adrian Curran

|Nov 08, 2024
Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption.

Gesham Magombedze, Elena Vendrame, Devi SenGupta

|May 10, 2024
HIV rebound in HIV controllers is associated with a specific fecal microbiome profile.

Yanhui Cai, Ondrej Podlaha, Steven G Deeks

|Jun 24, 2021
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy.

Devi SenGupta, Cynthia Brinson, Edwin DeJesus

Pageof 2

Frequent Collaborators

2 joint publications

Michael J Peluso

2 joint publications

Beatriz Mothe

2 joint publications

Yovaninna Alarcón-Soto

2 joint publications

Lucia Bailón